Correction: Bridging Solutions in Dose-Finding Problems [Statistics in Biopharmaceutical Research, 6, (2014) 185-197, DOI 10.1080/19466315.2014.906365];Bridging Solutions in Dose-Finding Problems

Statistics in Biopharmaceutical Research

Volumn 6, Issue 2, 2014, Pages 185-197

  O'Quigley, John ^a   Iasonos, Alexia ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Calibration; Clinical trials; Continual reassessment method; Dose escalation; Pediatric trials; Pharmacokinetics; Phase 1 trials; Toxicity

Indexed keywords

CISPLATIN; TEMOZOLOMIDE;

ARTICLE; CALIBRATION; CHILDHOOD CANCER; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; DRUG DOSE ESCALATION; HUMAN; MAXIMUM LIKELIHOOD METHOD; MAXIMUM TOLERATED DOSE; POPULATION; PROBABILITY; SAMPLE SIZE; SIMULATION; STATISTICAL DISTRIBUTION; TOXICITY;

EID: 84902194758     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1080/19466315.2015.1004876     Document Type: Erratum

References (10)

1. Chu, P.L., Lin, Y., and Shih, W.J. (2009), "Unifying CRM and EWOC Designs for Phase I Cancer Clinical Trials," Journal of Statistical Planning and Inference, 139, 1146-1163.
2. Geoerger, B., Vassal, G., Doz, F., O'Quigley, J., Wartelle, M., Watson, A.J., Raquin, M.A., Frappaz, D., Chastagner, P., Gentet, J.C., Rubie, H., Couanet, D., Geoffray, A., Djafari, L., Margison, G.P., and Pein, F. (2005), "Dose Finding and O6-Alkylguanine-DNA Alkyltransferase Study of Cisplatin Combined With Temozolomide in Paediatric Solid Malignancies," British Journal of Cancer, 93, 529-537.
3. Iasonos, A., and O'Quigley, J. (2012), "Interplay of Priors and Skeletons in Two-Stage Continual Reassessment Method," Statistics in Medicine, 31, 4321-4336.
4. O'Quigley, J. (2005), "Retrospective Analysis of Sequential Dose-Finding Designs," Biometrics, 61, 749-756.
5. O'Quigley, J., Pepe, M., and Fisher, L. (1990), "Continual Reassessment Method: A Practical Design for Phase I Clinical Trials in Cancer," Biometrics, 46, 33-48.
6. O'Quigley, J., and Reiner, E. (1998), "A Stopping Rule for the Continual Reassessment Method," Biometrika, 85, 741-748.
7. O'Quigley, J., Paoletti, X., Maccario, J. (2002), "Non-parametric Optimal Design in Dose Finding Studies," Biostatistics, 3, 51-56.
8. O'Quigley, J., Shen, L., and Gamst, A. (1999), "Two-Sample Continual Reassessment Method," Journal of Biopharmaceutical Statistics, 9, 17-44.
9. Shen, L.Z., and O'Quigley, J. (1996), "Consistency of Continual Reassessment Method in Dose Finding Studies," Biometrika, 83, 395-406.
10. Yuan, Y., and Yin, G. (2011), "Dose-Response Curve Estimation: A Semiparametric Mixture Approach," Biometrics, 67, 1543-1554.